Evidence map›Paper›PMID 42730589›Full record

ArticleCNS neuroscience & therapeutics2026

Developmental Deficiency of Oligodendrocytes and Myelination in the Central Nervous System of the Fetal Alcohol Syndrome Mouse Model.

Xiaoling Liang, Rulan Yi, Zhidan Ke, Yi Zhang, Liang Zhou

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaoling LiangKey Laboratory of Anesthesia and Organ Protection of the Ministry of Education (In Cultivation), Zunyi Medical University, Zunyi, China.
Rulan YiKey Laboratory of Anesthesia and Organ Protection of the Ministry of Education (In Cultivation), Zunyi Medical University, Zunyi, China.
Zhidan KeKey Laboratory of Anesthesia and Organ Protection of the Ministry of Education (In Cultivation), Zunyi Medical University, Zunyi, China.
Yi ZhangKey Laboratory of Anesthesia and Organ Protection of the Ministry of Education (In Cultivation), Zunyi Medical University, Zunyi, China.
Liang ZhouKey Laboratory of Anesthesia and Organ Protection of the Ministry of Education (In Cultivation), Zunyi Medical University, Zunyi, China.ORCID https://orcid.org/0009-0001-5534-763X

Funding

National Natural Science Foundation of China 82460242Scientific Project of Guizhou Province Qian Comprehensive Basic Science ZD[2026]160the project of Key Laboratory of Anesthesia and organ protection, Zunyi Medical University 3000311-0008
6 · The paper itself

Abstract

backgroundFetal alcohol spectrum disorder (FASD) is a severe condition characterized by physical and neurodevelopmental abnormalities in the fetus resulting from prenatal alcohol exposure (PAE) or prenatal and lactation alcohol exposure (PLAE). Behavioral abnormalities associated with white matter damage have been extensively investigated in FASD patients and animal models, which suggested the involvement of myelination in FASD pathology. However, the impact of FASD on oligodendrocytes (OLs) and myelination within the central nervous system (CNS) and the underlying mechanisms are little discovered. This study aimed to reveal the effect and role of PLAE on CNS myelination in a FASD mouse model.

methodsWe set up a PLAE approach to generate the FASD mouse model to explore the effects of FASD on CNS myelination. Open-field test, elevated plus maze, and tail suspension test were used to evaluate possible behavior deficiency of the FASD mice. Myelination in the cortex and hippocampus of the FASD mice was detected at postnatal days 14, 21, and 90 (P14, P21, and P 90). Then we counted the number of oligodendrocyte precursor cells (OPCs) and mature oligodendrocytes (mOLs) to reveal the cell fates of oligodendrocyte lineage cells in the FASD mice. Next, we set up BLBP+/GFAP+ double-staining to monitor the possible dysfunction of radial glial cells, which may contribute to the myelination deficiency in FASD mice. Finally, an FDA-approved pro-myelination drug, clemastine fumarate (CF), was used to validate the possible advantages of myelin restoration and behavior defects in the FASD mice.

resultsImpaired myelination was observed in the cortex and hippocampus of the male FASD offspring, associated with hyperactivity-like behaviors, whereas the female FASD mice exhibited delayed myelin formation and normal behaviors, indicating a gender-specific manner of FASD pathology. Furthermore, the different myelination deficiency between male and female FASD mice is due to the fact that only the male FASD mice exhibited a failure of oligodendrocyte differentiation. Additionally, FASD exerts an impact on the quantity and differentiation of radial glia cells, which may contribute to the myelination defect. Finally, CF-treated male FASD mice showed myelin regeneration, leading to partial alleviation of behavioral abnormality in the male FASD mice.

conclusionOur data reveal a gender-related deficiency of CNS myelination in the FASD mouse model, suggesting a potential therapy target for FASD.

Indexed as

Central Nervous SystemFetal Alcohol Spectrum DisordersMyelin SheathOligodendrogliaAnimalsAnimals, NewbornDisease Models, AnimalEthanolFemaleMaleMiceMice, Inbred C57BLPregnancyEthanolfetal alcohol syndromemyelinationoligodendrocytesprenatal and lactation alcohol exposureradial glia cells

Identifiers

PMID42730589
PMCPMC13570189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.